MED-CLINDAMYCIN CAPSULE

מדינה: קנדה

שפה: אנגלית

מקור: Health Canada

מרכיב פעיל:

CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE)

זמין מ:

GENERIC MEDICAL PARTNERS INC

קוד ATC:

J01FF01

INN (שם בינלאומי):

CLINDAMYCIN

כמות:

150MG

טופס פרצבטיות:

CAPSULE

הרכב:

CLINDAMYCIN (CLINDAMYCIN HYDROCHLORIDE) 150MG

מסלול נתינה (של תרופות):

ORAL

יחידות באריזה:

100

סוג מרשם:

Prescription

איזור תרפויטי:

LINCOMYCINS

leaflet_short:

Active ingredient group (AIG) number: 0105830002; AHFS:

מצב אישור:

APPROVED

תאריך אישור:

2017-03-28

מאפייני מוצר

Med-Clindamycin (Clindamycin Hydrochloride Capsules)
Page 1 of 33
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
MED-CLINDAMYCIN
Clindamycin Hydrochloride Capsules
Capsules, 150 mg and 300 mg clindamycin, Oral
USP
Antibiotic
Generic Medical Partners Inc.
1500 Don Mills Road, Suite 711
Toronto, Ontario
M3B 3K4
Date of Initial Authorization:
March 28, 2017
Date of Revision:
June 2, 2022
Submission Control Number: 262519
Med-Clindamycin (Clindamycin Hydrochloride Capsules)
Page 2 of 33
RECENT MAJOR LABEL CHANGES
4 DOSAGE AND ADMINISTRATION, 4.2 Recommended Dose
and Dosage Adjustment
06/2022
7 WARNINGS AND PRECAUTIONS, Renal
06/2022
TABLE OF CONTENTS
SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF
AUTHORIZATION ARE NOT LISTED.
RECENT MAJOR LABEL
CHANGES…………………………………………………..…..………………….…..…..…………2
TABLE OF
CONTENTS……………………………………………………………………………………………..……….…………2
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................................4
1 INDICATIONS
......................................................................................................................4
1.1 Pediatrics
.................................................................................................................4
1.2 Geriatrics
.................................................................................................................5
2
CONTRAINDICATIONS..........................................................................................................5
4 DOSAGE AND
ADMINISTRATION..........................................................................................5
4.1 Dosing Considerations
..............................................................................................5
4.2 Recommended Dose and Dosage Adjustment
...........................................................5
4.4 Administration
.